PlainRecalls
FDA Drug Low Class III Terminated

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01

Reported: September 19, 2018 Initiated: August 28, 2018 #D-1184-2018

Product Description

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01

Reason for Recall

Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point

Details

Recalling Firm
Pfizer Inc.
Units Affected
1,580 vials
Distribution
Nationwide USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01. Recalled by Pfizer Inc.. Units affected: 1,580 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point
Which agency issued this recall?
This recall was issued by the FDA Drug on September 19, 2018. Severity: Low. Recall number: D-1184-2018.